Literature DB >> 1993386

Bone growth factors.

S Mohan1, D J Baylink.   

Abstract

Bone volume is determined by the relative rates of bone formation and bone resorption. Recent research in several laboratories suggests that growth factors may act locally to modulate bone formation by stimulating osteoblast proliferation and activity. A number of bone-derived growth factors have been isolated and characterized from bone matrix extracts and from media conditioned by bone cells and bone organs in culture. The growth factors found in bone matrix include insulinlike growth factors I and II, transforming growth factor-beta, acidic and basic fibroblast growth factor, platelet-derived growth factor, and bone morphogenetic proteins. Conditioned medium from bone cells contains several of these growth factors and also hematopoietic factors. These bone matrix-derived growth factors have different biologic activities, including mitogenic, differentiating, chemotactic, and osteolytic activities. Evidence suggests that bone cells produce substantial quantities of growth factors for extracellular storage in bone matrix. Apart from being produced for extracellular storage, it is possible that growth factors secreted by bone cells have acute effects on their neighboring osteoblastic cells, i.e., paracrine action, or on themselves, i.e., autocrine action. The release of matrix-stored growth factors by bone resorption may mean that growth factors act as delayed paracrine agents, e.g., osteoblasts deposit growth factors in bone and later when these growth factors are released from bone via bone resorption, the growth factors stimulate osteoblast precursors to proliferate. The findings that bone is a storehouse for growth factors and that bone cells in culture produce and respond to bone growth factors suggest bone growth factors may act as potential determinants of local bone formation. This review is focused on the structure, regulation, and biologic actions of the known bone growth factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993386

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  64 in total

1.  Dose-dependent effects of combined IGF-I and TGF-beta1 application in a sheep cervical spine fusion model.

Authors:  F Kandziora; R Pflugmacher; M Scholz; J Schäfer; G Schollmeier; G Schmidmaier; G Duda; M Raschke; N P Haas
Journal:  Eur Spine J       Date:  2002-11-08       Impact factor: 3.134

2.  The use of autologous blood-derived growth factors in bone regeneration.

Authors:  Roberto Civinini; Armando Macera; Lorenzo Nistri; Birgit Redl; Massimo Innocenti
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

3.  Bone regeneration in osseous defects using hydroxyapatite graft and the extent of ossification in osseous defects treated without grafts: a comparative evaluation.

Authors:  Ravi Shankar; Deepak Singh; Shoyeb Shaikh; Gaurav Singh; Anurag Yadav; Ravi Jain
Journal:  J Maxillofac Oral Surg       Date:  2011-04-22

4.  [Platelet-rich plasma combined with autologous cancellous bone : An alternative therapy for persistent non-union?].

Authors:  M Hakimi; P Jungbluth; S Thelen; M Betsch; W Linhart; S Flohé; J Windolf; M Wild
Journal:  Unfallchirurg       Date:  2011-11       Impact factor: 1.000

5.  Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms.

Authors:  Walter Geremicca; Carla Fonte; Sisto Vecchio
Journal:  Blood Transfus       Date:  2010-04       Impact factor: 3.443

6.  Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.

Authors:  T Yamaguchi; M Kanatani; M Yamauchi; H Kaji; T Sugishita; D J Baylink; S Mohan; K Chihara; T Sugimoto
Journal:  Calcif Tissue Int       Date:  2006-01-06       Impact factor: 4.333

Review 7.  Platelet-rich plasma and platelet gel: a review.

Authors:  Peter A M Everts; Johannes T A Knape; Gernot Weibrich; Jacques P A M Schönberger; Johannes Hoffmann; Eddy P Overdevest; Henk A M Box; André van Zundert
Journal:  J Extra Corpor Technol       Date:  2006-06

8.  Interleukin-4 as a bone regulatory factor: effects on murine osteoblast-like cells.

Authors:  J A Riancho; J González-Marcías; J A Amado; J M Olmos; J L Fernández-Luna
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

9.  Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism.

Authors:  Shoshana Yakar; Clifford J Rosen; Mary L Bouxsein; Hui Sun; Wilson Mejia; Yuki Kawashima; Yingjie Wu; Kelly Emerton; Valerie Williams; Karl Jepsen; Mitchell B Schaffler; Robert J Majeska; Oksana Gavrilova; Mariana Gutierrez; David Hwang; Patricia Pennisi; Jan Frystyk; Yves Boisclair; John Pintar; Héctor Jasper; Horacio Domene; Pinchas Cohen; David Clemmons; Derek LeRoith
Journal:  FASEB J       Date:  2008-10-24       Impact factor: 5.191

10.  Integrin expression regulates neuroblastoma attachment and migration.

Authors:  Amy Meyer; Cynthia M van Golen; Bhumsoo Kim; Kenneth L van Golen; Eva L Feldman
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.